Why the study?
What are the barriers to warfarin prescription in patients with atrial fibrillation?
What are the barriers to warfarin prescription in patients with atrial fibrillation?
Despite clear evidence of efficacy, warfarin is significantly underprescribed in eligible patients with atrial fibrillation due to multiple barriers.
No takes yet. Share an insight, caveat, or question.
Multifaceted barriers continue to limit warfarin use in eligible AF patients; leaves open targeted research on overcoming them.
Bungard et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: